Fig. 6From: Continued improvement in disease manifestations of acid sphingomyelinase deficiency for adults with up to 2 years of olipudase alfa treatment: open-label extension of the ASCEND trialLung high-resolution computed tomography (HRCT). Illustrative high-resolution computerized tomography image of ground glass opacity, reflecting sphingomyelin-filled infiltrates at baseline and after 1 or 2 years of olipudase alfa treatmentBack to article page